Skip to main content
Signal8
Jones Bryan profile photo

Bryan Jones

CIK: 0002045615

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (50.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Aardvark Therapeutics, Inc. logo
AARD

Aardvark Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Aardvark Therapeutics, Inc. logo
    AARD

    Aardvark Therapeutics, Inc.

    Oct 15, 2025
    Exercise(M)
    Direct
    1.3K shares at avg. $4.24$5K
  • Aardvark Therapeutics, Inc. logo
    AARD

    Aardvark Therapeutics, Inc.

    Jun 11, 2025
    Award(A)

    Stock Option (right to buy)

    Direct
    122K shares-

1-2 of 2

About Jones Bryan

Jones Bryan (SEC CIK 0002045615) files insider reports with the SEC as Chief Operating Officer of Aardvark Therapeutics, Inc. (AARD).

Signal8 holds 3 ownership filings by Jones Bryan (1 Form 3, 2 Form 4), filed between Feb 12, 2025 and Oct 16, 2025. Those filings report 2 transactions, from Jun 11, 2025 to Oct 15, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Jones Bryan's filings is in SAN DIEGO, CA.

Recent filings by Jones Bryan

  • Oct 15, 2025: Option exercise of AARD shares (Form 4, code M).
  • Jun 11, 2025: Grant or award of AARD derivative securities (Form 4, code A).

Other insiders filing for Aardvark Therapeutics, Inc. (AARD)

How to read Form 4 transaction codes